The authors aim to answer the following question: If the capital market reacts with abnormal stock returns to new product development success events, do these returns influence subsequent marketing decisions? Drawing on informational market feedback and managerial learning theories, the authors posit that when firms are uncertain about how responsive the product market will be to their marketing activities, signals received from the capital market help them update their beliefs about the product market’s responsiveness. In the pharmaceutical context, the authors decompose the abnormal returns at a new drug approval event into components that the firm can and cannot predict (i.e., predicted and unpredicted abnormal returns) and find that the postapproval advertising budget is larger when unpredicted abnormal approval returns are higher. Furthermore, this tendency is more pronounced for spending on detailing than for direct-to-consumer advertising. Consistent with these higher budgets, the authors find that postlaunch advertising is more effective when unpredicted abnormal approval returns are higher, particularly for detailing spending (vs. direct-to-consumer advertising). Overall, this study suggests that information flows from the capital market’s initial perceptions at new product introduction play an important role in subsequent marketing decisions in the product market.
AndrewsRick L.AnsariAsimCurrimImran S. (2002), “Hierarchical Bayes Versus Finite Mixture Cojoint Analysis Models: A Comparison of Fit, Prediction, and Partworth Recovery,” Journal of Marketing Research, 39 (1), 87–98.
2.
BaiJenniePhilipponThomasSavovAlex (2016), “Have Financial Markets Become More Informative?” Journal of Financial Economics, 122 (3), 625–54.
3.
BakkeTor-EricWhitedToni M. (2010), “What Firms Follow the Market? An Analysis of Corporate Investment Decisions,” Review of Financial Studies, 23 (5), 1941–80.
4.
BattalioRobertMendenhallRichard (2005), “Earnings Expectations, Investor Trade Size, and Anomalous Returns around Earnings Announcements,” Journal of Financial Economics, 77 (2), 289–319.
5.
BerndtErnst R.BuiLindaReileyDavid R.UrbanGlen L. (1995), “Information, Marketing, and Pricing in the U.S. Antiulcer Drug Market,” American Economic Review, 85 (2), 100–05.
6.
BondPhilipEdmansAlexGoldsteinItay (2012), “The Real Effects of Financial Markets,” Annual Review of Financial Economics, 4, 339–60.
7.
CaoZixiaSorescuAlina (2013), “Wedded Bliss or Tainted Love? Stock Market Reactions to the Introduction of Cobranded products,” Marketing Science, 32 (6), 939–59.
8.
CarhartMark M. (1997), “On Persistence in Mutual Fund Performance,” Journal of Finance, 52 (1), 57–82.
9.
ChakravartyAninditaGrewalRajdeep (2011), “The Stock Market in the Driver’s Seat! Implications for R&D and Marketing,” Management Science, 57 (9), 1594–1609.
10.
ChapmanCraigSteenburghThomas (2011), “An Investigation of Earnings Management Through Marketing Actions,” Management Science, 57 (1), 40–65.
11.
ChemmanurThomasYanAn (2009), “Product Market Advertising and New Security Issues,” Journal of Financial Economics, 92 (1), 40–65.
12.
ChenQiGoldsteinItayJiangWei (2007), “Price Informativeness and Investment Sensitivity to Stock Price,” Review of Financial Studies, 20 (3), 619–50.
13.
ChingAndrewIshiharaMasakazu (2010), “The Effect of Detailing on Prescription Decisions Under Uncertainty,” Journal of Quantitative Marketing and Economics, 8 (2), 123–65.
14.
DekimpeMarnik G.HanssensDominique M. (1999), “Sustained Spending and Persistent Response: A New Look at Long-Term Marketing Profitability,” Journal of Marketing Research, 36 (4), 397–412.
15.
DowJamesGortonGary (1997), “Stock Market Efficiency and Economic Efficiency: Is There a Connection?” Journal of Finance, 52 (3), 1087–29.
16.
DurnevArtMorckRandallYeungBernard (2004), “Value-Enhancing Capital Budgeting and Firm-Specific Stock Return Variation,” Journal of Finance, 59 (1), 65–105.
17.
DuttaShantanuNarasimhanOmRajivSurendra (1999), “Success in High-Technology Markets: Is Marketing Capability Critical?” Marketing Science, 18 (4), 547–68.
18.
EdmansAlexJayaramannSudarshanSchneemeierJan (2017), “The Source of Information in Prices and Investment-Price Sensitivity,” Journal of Financial Economics126 (1), 74–96.
19.
FamaEugene F. (1970), “Efficient Capital Markets: A Review of Theory and Empirical Work,” Journal of Finance, 25 (2), 282–417.
20.
FamaEugene F.FrenchKenneth R. (1993), “Common Risk Factors in the Returns on Stocks and Bonds,” Journal of Financial Economics, 33 (1), 3–56.
21.
FangEricLeeJongkukYangZhi (2015), “The Timing of Codevelopment Alliances in New Product Development Processes: Returns for Upstream and Downstream Partners,” Journal of Marketing, 79 (1), 64–82.
22.
FerreiraDanielFerreiraMiguel A.RaposoClara C. (2011), “Board Structure and Price Informativeness,” Journal of Financial Economics, 99 (3), 523–45.
23.
FischerMarcAlbersSonke (2010), “Patient- or Physician- Oriented Marketing: What Drives Primary Demand for Prescription Drugs?” Journal of Marketing Research, 47 (1), 103–21.
24.
FischerMarcAlbersSonkeWagnerNilsFrieMonica (2011), “Dynamic Marketing Budget Allocation Across Countries, Products, and Marketing Activities,” Marketing Science, 30 (4), 568–85.
25.
FoucaultThierryGehrigThomas (2008), “Stock Price Informativeness, Cross-Listings, and Investment Decisions,” Journal of Financial Economics, 88 (1), 146–68.
26.
GlostenLawrenceMilgromPaul, (1985), “Bid, Ask, and Transaction Prices in a Specialist Market with Heterogeneously Informed Traders,” Journal of Financial Economics, 14 (1), 71–100.
27.
GompersPaulIshiiJoyMetrickAndrew (2003), “Corporate Governance and Equity Prices,” Quarterly Journal of Economics, 118 (1), 107–55.
28.
HadlockCharlesPierceJoshua (2010), “New Evidence on Measuring Financial Constraints: Moving Beyond the KZ Index,” Review of Financial Studies, 23 (5), 1909–40.
29.
HayekFriedrich (1945), “The Use of Knowledge in Society,” American Economic Review, 35 (4), 519–30.
30.
HeflinFrankKrossWilliamSukInho (2016), “Asymmetric Effects of Regulation FD on Management Earnings Forecasts,” Accounting Review, 91 (1), 119–52.
31.
JoshiAmitHanssensDominique M. (2010), “The Direct and Indirect Effects of Advertising Spending on Firm Value,” Journal of Marketing, 74 (1), 20–33.
32.
KeBinHuddartStevenPetroniKathy (2003), “What Insiders Know About Future Earnings and How They Use It: Evidence from Insider Trades,” Journal of Accounting and Economics, 35 (3), 315–46.
33.
KremerSara T.M.BijmoltTammo H.A.LeeflangPeter S.H.WieringaJaap E. (2008), “Generalizations on Pharmaceutical Marketing Effectiveness,” International Journal of Research in Marketing, 25 (4), 234–46.
34.
KrossWilliamSukInho (2012), “Does Regulation FD Work? Evidence from Analysts’ Reliance on Public Disclosure,” Journal of Accounting and Economics, 53 (1/2), 225–48.
LuanY. JackieSudhirK. (2010), “Forecasting Marketing Mix Responsiveness for New Products,” Journal of Marketing Research, 47 (3), 444–57.
37.
LuoXueming (2007), “Consumer Negative Voice and Firm-Idiosyncratic Stock Returns,” Journal of Marketing, 71 (3), 75–88.
38.
LuoYuanzhi (2005), “Do Insiders Learn from Outsiders? Evidence from Mergers and Acquisitions,” Journal of Finance, 60 (4), 1951–82.
39.
MarkovitchDmitri G.GolderPeter N. (2008), “Using Stock Prices to Predict Market Event: Evidence on Sales Takeoff and Long-Term Firm Survival,” Marketing Science, 27 (4), 717–29.
40.
MarkovitchDmitri G.SteckelJoel H.YeungBernard (2005), “Using Capital Markets as Market Intelligence: Evidence from the Pharmaceutical Industry,” Management Science, 51 (10), 1467–80.
41.
MizikNatalie (2010), “The Theory and Practice of Management Through Marketing Actions,” Journal of Marketing Research, 47 (4), 594–611.
42.
NarayananSridharDesirajuRamaraoChintaguntaPradeep K. (2004), “Return on Investment Implications for Pharmaceutical Promotional Expenditures: The Role of Marketing-Mix Interactions,” Journal of Marketing, 68 (4), 90–105.
43.
NarayananSridharManchandaPuneetChintaguntaPradeep K. (2005), “Temporal Differences in the Role of Marketing Communication in the New Product Categories,” Journal of Marketing Research, 42 (3), 278–90.
44.
OsingaErnst C.LeeflangPeter S.H.WieringaJaap E. (2010), “Early Marketing Matters: A Time-Varying Parameter Approach to Persistence Modeling,” Journal of Marketing Research, 47 (2), 173–85.
45.
OsingaErnst C.LeeflangPeter S.H.SrinivasanShubaWieringaJaap E. (2011), “Why Do Firms Invest in Consumer Advertising with Limited Sales Response? A Shareholder Perspective,” Journal of Marketing, 75 (1), 109–24.
46.
PauwelsKoenSilva-RissoJorgeSrinivasanShubaHanssensDominique M. (2004), “New Products, Sales Promotions, and Firm Value: The Case of the Automobile Industry,” Journal of Marketing, 68 (4), 142–56.
47.
PiotroskiJoseph D.RoulstoneDarren T. (2005), “Do Insider Trades Reflect Both Contrarian Beliefs and Superior Knowledge about Future Cash-Flow Realizations?” Journal of Accounting and Economics, 39 (1), 55–81.
48.
RogersJonathan L.BuskirkAndrew Van (2013), “Bundled Forecasts and Selective Disclosure of Good News,” Journal of Accounting and Economics55 (1), 43–65.
49.
SabooAlok R.GrewalRajdeep (2013), “Stock Market Reactions to Customer and Competitor Orientations: The Case of Initial Public Offerings,” Marketing Science, 32 (1), 70–88.
50.
SeyhunH. Nejat (1992), “Why Does Aggregate Insider Trading Predict Future Stock Returns?” Quarterly Journal of Economics, 107 (4), 1303–31.
51.
SrinivasanShubaHanssensDominique M. (2009), “Marketing and Firm Value: Metrics, Methods, Findings, and Future Directions,” Journal of Marketing Research, 46 (3), 293–312.
52.
SrinivasanShubaPauwelsKoenSilva-RissoJorgeHanssensDominique M. (2009), “Product Innovations, Advertising and Stock Returns,” Journal of Marketing, 73 (1), 24–43.
53.
SoodAshishTellisGerard J. (2009), “Do Innovations Really Pay Off? Total Stock Market Returns to Innovation,” Marketing Science, 28 (3), 442–56.
54.
SubrahmanyamAvanidharTitmanSheridan (1999), “The Going-Public Decision and the Development of Financial Markets,” Journal of Finance, 54 (3), 1045–82.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
